Fluphenazin-neuraxpharm D25 Solution for Injection (Exempt Medicinal Product) – Pharmacy level recall – One batch
08/06/2023
Medicines for human use
Recall
We wish to advise you that batch number 200229, expiry date 08/2023, of Fluphenazin-neuraxpharm D25 Solution for Injection (an exempt medicinal product) is being recalled with immediate effect.
This recall is going to pharmacy level.
The batch subject to recall was supplied by Uniphar and Medisource. A copy of the Uniphar Recall Letter or the Medisource Recall Letter can be downloaded further below on this page.
Problem or issue
The reason for the recall is that out of specification results for related substances were detected in units from the batch.
Product information
- Authorisation number
- N/A. Exempt medicinal product
- Serial or batch number and expiry date
- Batch number 200229, expiry date 08/2023
- Human or veterinary medicine
- Human
- Target audience
- Pharmacists
- Recall level
- Pharmacy level recall
Actions to be taken
Information for pharmacists
Pharmacists are requested to perform the following actions:
- Check your current inventory and immediately quarantine any units of the batch within your pharmacy. For hospital pharmacies, this includes units at wards, clinics and any other relevant locations within the hospital.
- If you have supplied units from the batch to any other pharmacy, clinic or other such establishment, please forward a copy of the relevant recall letter to them, and request they quarantine and return any unused units to you.
- Return quarantined stock to your wholesaler by 23rd June 2023, where full credit will be issued.
Information for patients
As the recall is to pharmacy level, patients are not required to take any action.